Blueprint Medicines Research and Development Expenses 2014-2024 | BPMC
Blueprint Medicines research and development expenses for the twelve months ending September 30, 2024 were $0.353B, a 21.57% decline year-over-year.
- Blueprint Medicines annual research and development expenses for 2023 were $0.428B, a 10.41% decline from 2022.
- Blueprint Medicines annual research and development expenses for 2022 were $0.477B, a 20.57% decline from 2021.
- Blueprint Medicines annual research and development expenses for 2021 were $0.601B, a 83.88% increase from 2020.